Clinical Trials on Skin Diseases, Genetic

Total 377614 results

National Human Genome Research Institute (NHGRI)

Completed

Personalized Genomic Research

Genetics | Birth Defects | Genetic Disease | Genetic Linkage | Genetic Variation

United States
Queen Fabiola Children's University Hospital
Center of Human Genetics - ULB in Brussels; Interuniversity Institute of Bioinformatics...

Unknown

Method of Genetic Analysis in Genodermatoses (GENODERM)

Genodermatosis | Rare Genetic Disease With Cutaneous Expression

Belgium
The University of Hong Kong
The Hong Kong Polytechnic University

Active, not recruiting

Epidemiological Survey and Genetic Analysis of AD Patients in Hong Kong

Eczema | Atopic Dermatitis | Genetic Skin Disease

Hong Kong
Regeneron Pharmaceuticals
Sanofi

Completed

Efficacy and Safety of Dupilumab in Participants ≥12 to <18 Years of Age, With Moderate-to-severe Atopic Dermatitis

Hypersensitivity, Immediate | Dermatitis, Atopic | Moderate-to-Severe Atopic Dermatitis | Dermatitis, Dermatitis Atopic | Eczema, Skin Diseases, Skin | Diseases Genetic, Genetic | Diseases Inborn, Skin | Disease, Eczematous Skin | Hypersensitivity, Immune System Diseases

United States, Canada
Boston University

Active, not recruiting

Genetics of Ehlers-Danlos Syndrome

Ehlers-Danlos Syndrome | Genetics Syndrome

United States
National Institute of Arthritis and Musculoskeletal...

Recruiting

Effects of Treatments on Atopic Dermatitis

Skin Diseases | Skin Diseases, Genetic | Dermatitis | Eczema | Dermatitis, Atopic

United States
Eli Lilly and Company

Completed

A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis (ADhere-J)

Skin Diseases | Skin Diseases, Genetic | Dermatitis | Eczema | Dermatitis, Atopic

Japan
National Cancer Institute (NCI)

Completed

Study of Scaling Disorders and Other Inherited Skin Diseases

Genetic Skin Disease | Lamellar Ichthyosis | Keratosis Follicularis

United States
Joyce Teng

Recruiting

Computational Drug Repurposing for All EBS Cases

Healthy | Epidermolysis Bullosa | Genetic Skin Disease | Epidermolysis Bullosa Dystrophica | Epidermolysis Bullosa Simplex | Epidermolysis Bullosa, Junctional

United States
Yale University

Completed

A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists

Skin Diseases | Immune System Diseases | Hypersensitivity | Hypersensitivity, Immediate | Skin Diseases, Genetic | Dermatitis | Eczema | Skin Diseases, Eczematous | Dermatitis, Atopic | Genetic Disease, Inborn

United States
Amway (China) R&D Center

Recruiting

The Efficacy of Amway Herbal Drink to Improve Skin Anti-aging

Skin Laxity | Skin Lines

China
Shenzhen Precision Health Food Technology Co. Ltd...

Not yet recruiting

Study of Collagen Efficacy on Skin Anti-aging in 30 to 50-Year-Old Women

Skin Laxity | Skin Fold

China
Oslo University Hospital

Completed

Topical Gentamicin Nonsense Suppression Therapy of EB (GENTELBULL)

Epidermolysis Bullosa

Norway
Northwestern University
Ann & Robert H Lurie Children's Hospital of Chicago

Completed

Study of Alwextin® Cream in Treating Epidermolysis Bullosa

Epidermolysis Bullosa

United States
Ulthera, Inc

Completed

Feasibility Study: Evaluation of the Ulthera® System for Treatment of Abdominal Tissue

Skin Laxity | Skin Crepiness

United States
Centre Hospitalier Universitaire de Nice

Not yet recruiting

A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses (GENEPID)

Inflammatory Epidermal Genodermatoses

France
RHEACELL GmbH & Co. KG

Recruiting

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III, Cross-over)

Epidermolysis Bullosa

Austria
Shasa Hu
Berg, LLC

Completed

Topical BPM31510 3.0% Cream in Patients With Epidermolysis Bullosa

Epidermolysis Bullosa

United States
Scioderm, Inc.
Amicus Therapeutics

Completed

ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa

Epidermolysis Bullosa

Italy, Spain, Serbia, United States, Australia, Netherlands, Austria, Germany, Israel, Lithuania, France, United Kingdom, Poland
Scioderm, Inc.
Amicus Therapeutics

Terminated

Open Label Extension Study to Evaluate the Long-term Safety of Zorblisa (SD-101-6.0) in Patients With Epidermolysis Bullosa

Epidermolysis Bullosa

Poland, Spain, Serbia, Netherlands, United States, Austria, Australia, Israel, Germany, France, United Kingdom, Lithuania
Masonic Cancer Center, University of Minnesota

Terminated

Allogeneic Hematopoietic Stem Cell Transplant For Epidermolysis Bullosa

Epidermolysis Bullosa

United States
RHEACELL GmbH & Co. KG

Recruiting

Allogeneic ABCB5-positive Dermal Mesenchymal Stromal Cells for Treatment of Epidermolysis Bullosa (Phase III)

Epidermolysis Bullosa

United States
Masonic Cancer Center, University of Minnesota

Completed

Study of Cellutome System for Treatment of Individual Lesions in EB Pts

Epidermolysis Bullosa

United States
Masonic Cancer Center, University of Minnesota

Completed

Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs

Epidermolysis Bullosa

United States
IBSA Farmaceutici Italia Srl
Derming SRL

Completed

Aesthetic Performance and Tolerance of an Injective Intradermal Treatment for the Skin Roughness and Laxity of Back of the Hands

Skin Laxity | Skin Roughness

Italy
Masonic Cancer Center, University of Minnesota

Completed

MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs

Epidermolysis Bullosa

United States
Amryt Research Limited

Completed

Phase III Efficacy and Safety Study of Oleogel-S10 in Epidermolysis Bullosa (EASE)

Epidermolysis Bullosa

United States, Spain, Israel, Australia, France, Denmark, Switzerland, Italy, Hong Kong, Argentina, Austria, Brazil, Chile, Colombia, Czechia, Georgia, Germany, Greece, Hungary, Ireland, Romania, Russian Federation, Serbia, Singapore, U... and more
Guangdong HuaPeptides Biotechnology Co., Ltd.

Completed

Improved Skin Anti-aging Outcomes Associated With Collagen Fortified Consumption In 30 to 50-Year-old Women

Skin Laxity | Skin Lines

China
Rambam Health Care Campus

Withdrawn

Study to Evaluate the Efficacy of Tetracycline in Epidermolysis Bullosa

Epidermolysis Bullosa
Scioderm, Inc.
Amicus Therapeutics

Completed

Study of Effectiveness and Safety of SD-101 in Participants With Epidermolysis Bullosa

Epidermolysis Bullosa

United States
Scioderm, Inc.
Food and Drug Administration (FDA); Amicus Therapeutics

Terminated

Open-Label Extension Study to Evaluate the Safety of SD-101 Cream in Participants With Epidermolysis Bullosa

Epidermolysis Bullosa

United States
Amicus Therapeutics

Completed

Survey to Identify Burdens and Unmet Needs of Patients With Epidermolysis Bullosa

Epidermolysis Bullosa

United States
University Hospital Erlangen
Edimer Pharmaceuticals

Completed

Characterization of Sweat Gland Function in Patients With Recessively Inherited Hypohidrotic Ectodermal Dysplasia

Hypohidrotic Ectodermal Dysplasia

Germany
Sciton

Recruiting

Evaluation of Fractional Ablative Laser Treatment for Skin Conditions

Skin Laxity

United States
Goldman, Butterwick, Fitzpatrick and Groff
Galderma R&D

Not yet recruiting

Sculptra to Aid in Treatment of Arm Laxity

Skin Laxity
FA Corporation
University of Texas Southwestern Medical Center

Enrolling by invitation

Histological Study of the Effects of a 2910 nm Fiber Laser Technology

Skin Laxity

United States
University of California, Irvine

Completed

Combined Focused Ultrasound and Calcium Hydroxylapatitie Filler for Skin Laxity and Volume Restoration

Skin Laxity

United States
Sofwave Medical LTD

Completed

Safety and Efficacy of Sofwave Treatment to Lift Lax Skin

Skin Laxity

United States
Candela Corporation

Withdrawn

Bipolar RF Microneedling for Improved Laxity and Lift of the Submental and Neck Tissue and Effect on Elastin

Skin Laxity

United States
Ulthera, Inc

Terminated

Gene Expression Following Ultherapy® Treatment

Skin Laxity

United States
ThermiGen, LLC

Completed

Safety and Effectiveness Evaluation of the Device in Achieving Submental Lift

Skin Laxity

United States
Ulthera, Inc

Completed

Feasibility Study: Treatment of Post-surgery and Surgery Naive Patients Who Failed to Respond to a Previous Ulthera Treatment

Skin Laxity

United States
Candela Corporation

Recruiting

Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System

Skin Condition | Wrinkle | Skin Laxity

United States, Canada, Spain
Assiut University

Not yet recruiting

Clinical Presentation of Genetic Disorders in Patients Attending Genetic Outpatient Clinic of Assiut University Children Hospital

Genetic Disease Clinical Presentation in Patients Attending Genetics Outpatient Clinic of Assiut University Children Hospital
Goldman, Butterwick, Fitzpatrick and Groff
Galderma R&D

Not yet recruiting

Injectable Poly-L-Lactic Acid for Volumization and Adipogenesis of the Hip Dell

Skin Laxity

United States
University of Texas Southwestern Medical Center

Completed

Clinical Assessment of Skin Tightening and Contour Change of Submental Tissue Using Bipolar Radiofrequency Microneedling

Skin Laxity

United States
Sofwave Medical LTD

Completed

Treatment for Lifting Upper Arm Lax Skin

Lax Skin

United States
BTL Industries Ltd.

Completed

Safety and Efficacy of the BTL-785F Device for Non-invasive Reduction of Submental Fat

Skin Laxity

Bulgaria
Apyx Medical

Completed

Renuvion APR Device to Improve the Appearance of Lax Tissue in the Neck and Submental Region

Lax Skin

United States
Cynosure, Inc.

Completed

Rollover Study to Evaluate Histological Results of Radiofrequency Device Treatments on the Flanks

Skin Laxity

United States

Clinical Trials on Skin Diseases, Genetic

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uganda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations